
Buspirone Tablets
Form: Tablets
Strength: 5 mg, 7.5 mg, 10 mg, 15 mg, 30 mg
Reference Brands: Generics mainly and Buspar®(dis.cntd)
Category: Antipsychotropic Drugs
Buspirone tablets are FDA-approved in the United States for the management of generalized anxiety disorder (GAD) or the short-term relief of anxiety symptoms. As a non-scheduled medication, it offers a safer alternative to benzodiazepines with no risk of dependence. Manufacturing requires compliance with GMP standards, validated bioequivalence data for generics, and adherence to CNS safety labeling. In the European Union, buspirone is authorized via national procedures for similar indications. EU regulations require Risk Management Plans (RMPs) and post-marketing pharmacovigilance. To explore dossier-ready Buspirone tablets for global B2B sourcing, visit Pharmatradz.com.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Related Products
Risperidone Long-Acting Injection
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg vials/syringes
Form: Long-Acting Injection
Reference Brands: Risperdal Consta(US &EU)
View Details Get EnquiryZuclopenthixol ong-acting IM Injection (Depot)
Strength: 200 mg/mL, 500 mg/mL
Form: Long-acting IM Injection (Depot)
Reference Brands: Clopixol Depot®(US)
View Details Get EnquiryZuclopenthixol Short-acting Intramuscular Injection
Strength: 50 mg/mL
Form: Short-acting Intramuscular Injection
Reference Brands: Clopixol-Acuphase®
View Details Get EnquiryZuclopenthixol tablets
Strength: 10 mg, 25 mg, 40 mg
Form: Oral Tablets
Reference Brands: Clopixol®(EU)
View Details Get Enquiry